World Heart To Submit IDE For VAD By End Of 2000; Canadian Trials Delayed
This article was originally published in The Gray Sheet
Executive Summary
World Heart Corp. will apply for an investigational device exemption at the end of 2000 as the first step toward a PMA filing for the HeartSaverVAD ventricular assist device, according to the company.